Taking hormone replacement therapy (HRT) for the menopause, even for just a few years, is associated with a significantly increased risk of developing the two most common types of ovarian cancer, according to a detailed re-analysis of all the available evidence, published in The Lancet.
The findings from a meta-analysis of 52 epidemiological studies, involving a total of 21488 women with ovarian cancer, almost all from North America, Europe and Australia, indicate that women who use HRT for just a few years are about 40% more likely to develop ovarian cancer than women who have never taken HRT.
"For women who take HRT for 5 years from around age 50, there will be about one extra ovarian cancer for every 1000 users and one extra ovarian cancer death for every 1700 users", explains study co-author Professor Sir Richard Peto from the University of Oxford in the UK.
Although HRT use fell rapidly about a decade ago, this decrease has now levelled off and in the UK and USA alone about 6 million women are still taking HRT. Existing WHO, US and European HRT guidelines do not mention ovarian cancer, and UK guidelines (currently being revised) state only that ovarian cancer might be increased with long-term use. Previous studies had been too small to assess reliably the risks from just a few years of HRT use.
The international Collaborative Group on Epidemiological Studies of Ovarian Cancer, organised by the University of Oxford and involving over 100 researchers worldwide, analysed individual participant data from 52 studies—virtually all of the epidemiological evidence ever collected on HRT use and ovarian cancer. There was a significantly increased risk of developing ovarian cancer in current or recent users (ie, women who had used HRT within the past 5 years), but although the risk of ovarian cancer fell over time after stopping treatment, women who had used HRT for at least 5 years still had a somewhat increased risk of ovarian cancer 10 years later.
The effect of HRT on the risk of developing ovarian cancer was the same for the two main types of HRT (preparations containing oestrogen only, or oestrogen together with a progestagen). Likewise, the proportional increase in risk was not materially affected by the age at which HRT began, body size, past use of oral contraceptives, hysterectomy, alcohol use, tobacco use, or family history of breast or ovarian cancer.
There are, however, four main types of ovarian cancer, and an increase in risk was seen only for the two most common types (serous and endometrioid ovarian cancers), and not for the two less common types (mucinous and clear cell ovarian cancers).
According to study co-author Professor Dame Valerie Beral, also from the University of Oxford, "The definite risk of ovarian cancer even with less than 5 years of HRT is directly relevant to today's patterns of use—with most women now taking HRT for only a few years—and has implications for current efforts to revise UK and worldwide guidelines."
Explore further: Latest evidence on using hormone replacement therapy for treating menopausal symptoms
More information: The Lancetб http://ift.tt/1isrvyQ (14)61687-1/abstract
Medical Xpress on facebook
Related Stories
Latest evidence on using hormone replacement therapy for treating menopausal symptoms
Dec 18, 2014
Hormone replacement therapy (HRT) is the most effective treatment for menopausal symptoms, in particular for younger women at the onset of the menopause, suggests a new review published today in The Obstetrician & Gynaecologist (TOG). ...
Increasing height and body mass index are risk factors for ovarian cancer
Apr 03, 2012
(Medical Xpress) -- Taller women are at a greater risk of ovarian cancer, a large study has found after bringing together all the evidence from clinical studies carried out worldwide.
Skirt size increase linked to 33 percent greater postmenopausal breast cancer risk
Sep 24, 2014
Going up a skirt size over a period of 10 years between your mid 20s and mid 50s is linked to a 33 percent greater risk of developing breast cancer after the menopause, finds a large observational study published in the online ...
Mesothelial cells promote ovarian cancer metastasis
Sep 09, 2014
Less than half of the women diagnosed with ovarian cancer will survive beyond 5 years. Ovarian cancer readily spreads to abdominal organs, which are covered by a layer of cells called the mesothelium. Ovarian cancer cells ...
Women should still be concerned about hormone replacement therapy, researchers say
Dec 21, 2011
McMaster University researchers have found consistent evidence that use of hormone replacement therapy (HRT) is associated with breast cancer globally. This study comes at a time when more women are again asking for this ...
Recommended for you
New research shows possibility of cure for HPV positive throat cancer patients
51 seconds ago
Patients with cancer of the throat caused by the Human Papilloma virus (HPV+) have a better prognosis than those who are negative for the virus (HPV-). Now, for the first time, researchers have shown with convincing evidence ...
New radiotracer helps avoid neck dissection in patients with early head and neck cancer
1 minute ago
The discovery that the identification and biopsy of the first lymph node to which a cancer spreads (the sentinel node) can lead to more accurate diagnosis and treatment has revolutionised the management of breast cancer. ...
Mammography rates down since 2009 USPSTF guidelines
9 hours ago
(HealthDay)—Since the publication of the U.S. Preventive Services Task Force guidelines for mammography in 2009, there has been a decrease in mammography rates among white, Hispanic, and Asian women, according ...
Two cell-signaling molecules found to suppress the spread of melanoma
14 hours ago
In what is believed to be the largest epigenetic analysis to date of cell-signaling molecules in early-stage melanoma, researchers at NYU Langone Medical Center and its Laura and Isaac Perlmutter Cancer Center have identified ...
Fatal cancer found among Southern Nevada residents likely caused by asbestos in nature
15 hours ago
Southern Nevada counties that include Las Vegas show high proportions of women and younger residents coming down with a rare and aggressive cancer more commonly found in older men occupationally exposed to ...
Researchers design 'evolutionary trap' to thwart drug resistance
15 hours ago
Cancer is a notoriously evasive disease. It can adopt multiple identities, accumulating mutations or even gaining or losing whole chromosomes to create genetic variants of itself that are resistant to whatever ...
User comments
Please sign in to add a comment. Registration is free, and takes less than a minute. Read more
Click here to reset your password.
Sign in to get notified via email when new comments are made.
© Medical Xpress 2011-2014, Science X network
Taking hormone replacement therapy (HRT) for the menopause, even for just a few years, is associated with a significantly increased risk of developing the two most common types of ovarian cancer, according to a detailed re-analysis of all the available evidence, published in The Lancet.
The findings from a meta-analysis of 52 epidemiological studies, involving a total of 21488 women with ovarian cancer, almost all from North America, Europe and Australia, indicate that women who use HRT for just a few years are about 40% more likely to develop ovarian cancer than women who have never taken HRT.
"For women who take HRT for 5 years from around age 50, there will be about one extra ovarian cancer for every 1000 users and one extra ovarian cancer death for every 1700 users", explains study co-author Professor Sir Richard Peto from the University of Oxford in the UK.
Although HRT use fell rapidly about a decade ago, this decrease has now levelled off and in the UK and USA alone about 6 million women are still taking HRT. Existing WHO, US and European HRT guidelines do not mention ovarian cancer, and UK guidelines (currently being revised) state only that ovarian cancer might be increased with long-term use. Previous studies had been too small to assess reliably the risks from just a few years of HRT use.
The international Collaborative Group on Epidemiological Studies of Ovarian Cancer, organised by the University of Oxford and involving over 100 researchers worldwide, analysed individual participant data from 52 studies—virtually all of the epidemiological evidence ever collected on HRT use and ovarian cancer. There was a significantly increased risk of developing ovarian cancer in current or recent users (ie, women who had used HRT within the past 5 years), but although the risk of ovarian cancer fell over time after stopping treatment, women who had used HRT for at least 5 years still had a somewhat increased risk of ovarian cancer 10 years later.
The effect of HRT on the risk of developing ovarian cancer was the same for the two main types of HRT (preparations containing oestrogen only, or oestrogen together with a progestagen). Likewise, the proportional increase in risk was not materially affected by the age at which HRT began, body size, past use of oral contraceptives, hysterectomy, alcohol use, tobacco use, or family history of breast or ovarian cancer.
There are, however, four main types of ovarian cancer, and an increase in risk was seen only for the two most common types (serous and endometrioid ovarian cancers), and not for the two less common types (mucinous and clear cell ovarian cancers).
According to study co-author Professor Dame Valerie Beral, also from the University of Oxford, "The definite risk of ovarian cancer even with less than 5 years of HRT is directly relevant to today's patterns of use—with most women now taking HRT for only a few years—and has implications for current efforts to revise UK and worldwide guidelines."
Explore further: Latest evidence on using hormone replacement therapy for treating menopausal symptoms
More information: The Lancetб http://ift.tt/1isrvyQ (14)61687-1/abstract
Medical Xpress on facebook
Related Stories
Latest evidence on using hormone replacement therapy for treating menopausal symptoms
Dec 18, 2014
Hormone replacement therapy (HRT) is the most effective treatment for menopausal symptoms, in particular for younger women at the onset of the menopause, suggests a new review published today in The Obstetrician & Gynaecologist (TOG). ...
Increasing height and body mass index are risk factors for ovarian cancer
Apr 03, 2012
(Medical Xpress) -- Taller women are at a greater risk of ovarian cancer, a large study has found after bringing together all the evidence from clinical studies carried out worldwide.
Skirt size increase linked to 33 percent greater postmenopausal breast cancer risk
Sep 24, 2014
Going up a skirt size over a period of 10 years between your mid 20s and mid 50s is linked to a 33 percent greater risk of developing breast cancer after the menopause, finds a large observational study published in the online ...
Mesothelial cells promote ovarian cancer metastasis
Sep 09, 2014
Less than half of the women diagnosed with ovarian cancer will survive beyond 5 years. Ovarian cancer readily spreads to abdominal organs, which are covered by a layer of cells called the mesothelium. Ovarian cancer cells ...
Women should still be concerned about hormone replacement therapy, researchers say
Dec 21, 2011
McMaster University researchers have found consistent evidence that use of hormone replacement therapy (HRT) is associated with breast cancer globally. This study comes at a time when more women are again asking for this ...
Recommended for you
New research shows possibility of cure for HPV positive throat cancer patients
51 seconds ago
Patients with cancer of the throat caused by the Human Papilloma virus (HPV+) have a better prognosis than those who are negative for the virus (HPV-). Now, for the first time, researchers have shown with convincing evidence ...
New radiotracer helps avoid neck dissection in patients with early head and neck cancer
1 minute ago
The discovery that the identification and biopsy of the first lymph node to which a cancer spreads (the sentinel node) can lead to more accurate diagnosis and treatment has revolutionised the management of breast cancer. ...
Mammography rates down since 2009 USPSTF guidelines
9 hours ago
(HealthDay)—Since the publication of the U.S. Preventive Services Task Force guidelines for mammography in 2009, there has been a decrease in mammography rates among white, Hispanic, and Asian women, according ...
Two cell-signaling molecules found to suppress the spread of melanoma
14 hours ago
In what is believed to be the largest epigenetic analysis to date of cell-signaling molecules in early-stage melanoma, researchers at NYU Langone Medical Center and its Laura and Isaac Perlmutter Cancer Center have identified ...
Fatal cancer found among Southern Nevada residents likely caused by asbestos in nature
15 hours ago
Southern Nevada counties that include Las Vegas show high proportions of women and younger residents coming down with a rare and aggressive cancer more commonly found in older men occupationally exposed to ...
Researchers design 'evolutionary trap' to thwart drug resistance
15 hours ago
Cancer is a notoriously evasive disease. It can adopt multiple identities, accumulating mutations or even gaining or losing whole chromosomes to create genetic variants of itself that are resistant to whatever ...
User comments
Please sign in to add a comment. Registration is free, and takes less than a minute. Read more
Click here
to reset your password.
Sign in to get notified via email when new comments are made.
© Medical Xpress 2011-2014, Science X network
No comments:
Post a Comment